CXCR2 and neoplasm: Inhibition of CXC chemokine receptor type 2 (CXCR2), a G-protein-coupled receptor, blocked the tumor angiogenesis via downregulation of connective tissue growth factor (Ctgf) expression in the tumor-associated fibroblasts (TAFs), leading to an anti-tumor effect and significant survival extension11.